$2.86
8.33% day before yesterday
Nasdaq, Sep 19, 10:19 pm CET
ISIN
US03589W1027
Symbol
ANNX

Annexon Inc Stock price

$2.86
+0.67 30.59% 1M
+0.36 14.40% 6M
-2.27 44.25% YTD
-4.17 59.29% 1Y
-3.72 56.54% 3Y
-19.16 87.01% 5Y
-14.90 83.90% 10Y
-14.90 83.90% 20Y
Nasdaq, Closing price Fri, Sep 19 2025
+0.22 8.33%
ISIN
US03589W1027
Symbol
ANNX
Industry

Key metrics

Basic
Market capitalization
$314.3m
Enterprise Value
$87.3m
Net debt
positive
Cash
$227.0m
Shares outstanding
109.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
1.6
Financial Health
Equity Ratio
83.7%
Return on Equity
-47.2%
ROCE
-89.8%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-198.9m | $-237.9m
EBIT
$-201.1m | $-199.1m
Net Income
$-188.8m | $-155.3m
Free Cash Flow
$-156.3m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-59.4% | -56.6%
EBIT
-58.4% | -29.2%
Net Income
-63.9% | -12.4%
Free Cash Flow
-53.5%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-1.3
FCF per Share
$-1.4
Short interest
11.5%
Employees
103
Rev per Employee
$0.0
Show more

Is Annexon Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,012 stocks worldwide.

Annexon Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Annexon Inc forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Annexon Inc forecast:

Buy
93%
Hold
7%

Financial data from Annexon Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 35 35
18% 18%
-
- Research and Development Expense 166 166
71% 71%
-
-199 -199
59% 59%
-
- Depreciation and Amortization 2.15 2.15
0% 0%
-
EBIT (Operating Income) EBIT -201 -201
58% 58%
-
Net Profit -189 -189
64% 64%
-

In millions USD.

Don't miss a Thing! We will send you all news about Annexon Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Annexon Inc Stock News

Neutral
Seeking Alpha
13 days ago
Annexon, Inc. (NASDAQ:ANNX ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 3:00 PM EDT Company Participants Douglas Love - CEO, President & Director Conference Call Participants Derek Archila - Wells Fargo Securities, LLC, Research Division Presentation Derek Archila Senior Equity Analyst All right, everyone. We'll get to the next fireside here.
Neutral
Seeking Alpha
16 days ago
Annexon, Inc. (NASDAQ:ANNX ) Cantor Global Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Douglas Love - CEO, President & Director Conference Call Participants Pete Stavropoulos - Cantor Fitzgerald & Co., Research Division Presentation Pete Stavropoulos Biotech Analyst So welcome to the Cantor Global Healthcare Conference. I'm Pete Stavropoulos, biotech analyst wi...
Neutral
GlobeNewsWire
25 days ago
BRISBANE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that Douglas Love, Esq.
More Annexon Inc News

Company Profile

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in South San Francisco, CA.

Head office United States
CEO Douglas Love
Employees 103
Founded 2011
Website annexonbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today